Brendan Smith - 14 Oct 2021 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Financial Officer
Signature: /s/ Michael Esposito, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 14 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 15 Oct 2021, 20:00:20 UTC
Previous filing: 14 Sep 2021
Next filing: 22 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney